Literature DB >> 29475963

Comparison of Urine 4-(Methylnitrosamino)-1-(3)Pyridyl-1-Butanol and Cotinine for Assessment of Active and Passive Smoke Exposure in Urban Adolescents.

Neal L Benowitz1,2, Natalie Nardone3, Shonul Jain4, Delia A Dempsey3,4, Newton Addo3, Gideon St Helen2,3, Peyton Jacob2,5.   

Abstract

Background: Many adolescents are exposed to tobacco smoke, from either active smoking (CS) or secondhand smoke (SHS) exposure. Tobacco-specific biomarkers of exposure include cotinine (detects use in past 2-4 days) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL; detects use for a month or longer). NNAL is expected to detect more intermittent tobacco exposure. We compared NNAL and cotinine as biomarkers of exposure to tobacco in urban adolescents and determined the optimal NNAL cutoff point to distinguish CS from SHS exposure.
Methods: Surplus urine samples, collected from 466 adolescents attending pediatric well or urgent care visits at Zuckerberg San Francisco General Hospital in 2013 to 2014, were assayed for cotinine and NNAL.
Results: Ninety-four percent of adolescents had measurable levels of NNAL compared with 87% for cotinine. The optimal NNAL cutoff point to distinguish CS from SHS was 9.6 pg/mL by latent class or 14.4 pg/mL by receiver-operating characteristic analysis. Cotinine and NNAL were strongly correlated, but the correlation slopes differed for active versus SHS-exposed adolescents. Among nonsmokers, NNAL levels were significantly higher in African American (median, 3.3 pg/mL) compared with other groups (0.9-1.9 pg/mL), suggesting greater exposure to SHS.Conclusions: Urine NNAL screening finds a large majority (94%) of urban adolescents are exposed to tobacco. African Americans are exposed to higher levels of SHS than other ethnic/racial groups.Impact: SHS is associated with significant medical morbidity in adolescents. Routine biochemical screening with NNAL or cotinine detects high prevalence of SHS exposure and should be considered as a tool to reduce SHS exposure in high-risk populations. Cancer Epidemiol Biomarkers Prev; 27(3); 254-61. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29475963      PMCID: PMC5835192          DOI: 10.1158/1055-9965.EPI-17-0671

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  30 in total

Review 1.  Psychosocial factors related to adolescent smoking: a critical review of the literature.

Authors:  S L Tyas; L L Pederson
Journal:  Tob Control       Date:  1998       Impact factor: 7.552

2.  Biochemical verification of tobacco use and cessation.

Authors: 
Journal:  Nicotine Tob Res       Date:  2002-05       Impact factor: 4.244

3.  Metabolites of a tobacco-specific lung carcinogen in the urine of elementary school-aged children.

Authors:  S S Hecht; M Ye; S G Carmella; A Fredrickson; J L Adgate; I A Greaves; T R Church; A D Ryan; S J Mongin; K Sexton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-11       Impact factor: 4.254

4.  Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.

Authors:  Maciej L Goniewicz; Christopher M Havel; Margaret Wilson Peng; Peyton Jacob; Delia Dempsey; Lisa Yu; Wioleta Zielinska-Danch; Bartosz Koszowski; Jan Czogala; Andrzej Sobczak; Neal L Benowitz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

5.  Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography-tandem mass spectrometry.

Authors:  Peyton Jacob; Christopher Havel; Do-Hoon Lee; Lisa Yu; Mark D Eisner; Neal L Benowitz
Journal:  Anal Chem       Date:  2008-10-08       Impact factor: 6.986

6.  Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activity.

Authors:  Neal L Benowitz; Gideon St Helen; Delia A Dempsey; Peyton Jacob; Rachel F Tyndale
Journal:  Pharmacogenet Genomics       Date:  2016-07       Impact factor: 2.089

7.  Longer term exposure to secondhand smoke and health outcomes in COPD: impact of urine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.

Authors:  Mark D Eisner; Peyton Jacob; Neal L Benowitz; John Balmes; Paul D Blanc
Journal:  Nicotine Tob Res       Date:  2009-07-08       Impact factor: 4.244

8.  Racial and ethnic differences in serum cotinine levels of cigarette smokers: Third National Health and Nutrition Examination Survey, 1988-1991.

Authors:  R S Caraballo; G A Giovino; T F Pechacek; P D Mowery; P A Richter; W J Strauss; D J Sharp; M P Eriksen; J L Pirkle; K R Maurer
Journal:  JAMA       Date:  1998-07-08       Impact factor: 56.272

9.  Urine nicotine metabolite concentrations in relation to plasma cotinine during low-level nicotine exposure.

Authors:  Neal L Benowitz; Katherine M Dains; Delia Dempsey; Brenda Herrera; Lisa Yu; Peyton Jacob
Journal:  Nicotine Tob Res       Date:  2009-06-12       Impact factor: 4.244

Review 10.  Assessing secondhand smoke using biological markers.

Authors:  Erika Avila-Tang; Wael K Al-Delaimy; David L Ashley; Neal Benowitz; John T Bernert; Sungroul Kim; Jonathan M Samet; Stephen S Hecht
Journal:  Tob Control       Date:  2012-09-02       Impact factor: 7.552

View more
  26 in total

1.  Secondhand smoke exposure and higher blood pressure in children and adolescents participating in NHANES.

Authors:  Shelley H Liu; Bian Liu; Alison P Sanders; Jeffrey Saland; Karen M Wilson
Journal:  Prev Med       Date:  2020-03-09       Impact factor: 4.018

2.  High exposure to nicotine among adolescents who use Juul and other vape pod systems ('pods').

Authors:  Maciej Lukasz Goniewicz; Rachel Boykan; Catherine R Messina; Alison Eliscu; Jonatan Tolentino
Journal:  Tob Control       Date:  2018-09-07       Impact factor: 7.552

Review 3.  Electronic Cigarettes: Past, Present, and Future: What Clinicians Need to Know.

Authors:  Stephen R Baldassarri
Journal:  Clin Chest Med       Date:  2020-12       Impact factor: 2.878

4.  Adolescent Exposure to Toxic Volatile Organic Chemicals From E-Cigarettes.

Authors:  Mark L Rubinstein; Kevin Delucchi; Neal L Benowitz; Danielle E Ramo
Journal:  Pediatrics       Date:  2018-03-05       Impact factor: 7.124

Review 5.  Biochemical Verification of Tobacco Use and Abstinence: 2019 Update.

Authors:  Neal L Benowitz; John T Bernert; Jonathan Foulds; Stephen S Hecht; Peyton Jacob; Martin J Jarvis; Anne Joseph; Cheryl Oncken; Megan E Piper
Journal:  Nicotine Tob Res       Date:  2020-06-12       Impact factor: 4.244

6.  Quantitative biochemical screening for marijuana use and concordance with tobacco use in urban adolescents.

Authors:  Neal Benowitz; Natalie Nardone; Gideon St Helen; Newton Addo; Peyton Jacob; Evangelia Liakoni; Shonul Jain; Shirin Hooshfar; Kara Lynch
Journal:  Drug Alcohol Depend       Date:  2019-09-25       Impact factor: 4.492

7.  Measuring e-cigarette addiction among adolescents.

Authors:  Erin A Vogel; Judith J Prochaska; Mark L Rubinstein
Journal:  Tob Control       Date:  2019-05-11       Impact factor: 7.552

Review 8.  What is the nicotine delivery profile of electronic cigarettes?

Authors:  Natalie Voos; Maciej L Goniewicz; Thomas Eissenberg
Journal:  Expert Opin Drug Deliv       Date:  2019-09-13       Impact factor: 6.648

9.  Exposure to a Tobacco-Specific Carcinogen Among Adolescent Smokeless Tobacco Users in Rural California, United States.

Authors:  Benjamin W Chaffee; Peyton Jacob; Elizabeth T Couch; Neal L Benowitz
Journal:  Nicotine Tob Res       Date:  2020-10-08       Impact factor: 4.244

10.  Sources and Biomarkers of Secondhand Tobacco Smoke Exposure in Urban Adolescents.

Authors:  Natalie Nardone; Shonul Jain; Newton Addo; Gideon St Helen; Peyton Jacob; Neal L Benowitz
Journal:  Acad Pediatr       Date:  2019-12-20       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.